Sean Lee

Stock Analyst at HC Wainwright & Co.

(4.27)
# 439
Out of 5,006 analysts
92
Total ratings
38.46%
Success rate
29.89%
Average return
Main Sectors:

Stocks Rated by Sean Lee

Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10$12
Current: $6.41
Upside: +87.21%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.92
Upside: +74.67%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $1.85
Upside: +116.22%
Novavax
Aug 28, 2025
Assumes: Buy
Price Target: $10
Current: $9.46
Upside: +5.71%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5$5
Current: $0.95
Upside: +425.76%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2$13
Current: $6.56
Upside: +98.17%
Senseonics Holdings
Jul 8, 2025
Maintains: Buy
Price Target: $1.1$1.4
Current: $0.46
Upside: +202.38%
Plus Therapeutics
Jun 27, 2025
Maintains: Buy
Price Target: $5.5$3
Current: $0.73
Upside: +310.28%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.98
Upside: +1.63%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10$14
Current: $8.70
Upside: +60.92%
Reiterates: Buy
Price Target: $20
Current: $13.96
Upside: +43.27%
Reiterates: Buy
Price Target: $40
Current: $99.39
Upside: -59.75%
Reiterates: Buy
Price Target: $11
Current: $7.19
Upside: +52.99%